| P50 | author | Gert Lubec | Q37375880 |
| P2093 | author name string | Margit Rosner | |
| | Markus Hengstschläger | |
| | Oliver Brandau | |
| | Katharina Schipany | |
| | Bharanidharan Shanmugasundaram | |
| P2860 | cites work | Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis | Q21142646 |
| | Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development | Q24563399 |
| | mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells | Q24564276 |
| | An emerging role for TOR signaling in mammalian tissue and stem cell physiology | Q24629305 |
| | mTOR signaling in growth control and disease | Q24634174 |
| | Disease-specific induced pluripotent stem cells | Q24641981 |
| | Targeting the PI3K signaling pathway in cancer | Q24647554 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | The mTOR pathway and its role in human genetic diseases | Q28285976 |
| | Epigenetic memory in induced pluripotent stem cells | Q29547892 |
| | Molecular mechanisms of mTOR-mediated translational control | Q29615529 |
| | Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 |
| | Somatic coding mutations in human induced pluripotent stem cells | Q29616798 |
| | Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol | Q30164154 |
| | Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells | Q34022185 |
| | Induction of mesenchymal/epithelial marker expression in human amniotic fluid stem cells | Q34089699 |
| | Harnessing the potential of induced pluripotent stem cells for regenerative medicine | Q34182222 |
| | Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues | Q34333323 |
| | Neurogenic cells in human amniotic fluid. | Q34338842 |
| | Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture | Q34596358 |
| | Isolation of amniotic stem cell lines with potential for therapy | Q34598404 |
| | Renal differentiation of amniotic fluid stem cells | Q34714561 |
| | Genomic instability in induced stem cells | Q34816201 |
| | Amniotic fluid cells and human stem cell research: a new connection. | Q35005532 |
| | Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. | Q35640330 |
| | Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation | Q37074405 |
| | mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells | Q37194770 |
| | mTOR and the control of whole body metabolism | Q37406462 |
| | Novel sources of fetal stem cells: where do they fit on the developmental continuum? | Q37479813 |
| | ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective | Q37591306 |
| | Amniocentesis: technique and education. | Q37680641 |
| | On the origin of amniotic stem cells: of mice and men. | Q37743359 |
| | Molecular prenatal diagnosis: the impact of modern technologies. | Q37767195 |
| | Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program | Q37781243 |
| | Investigating monogenic and complex diseases with pluripotent stem cells | Q37851013 |
| | Turning the pyramid of prenatal care | Q37851291 |
| | Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 |
| | Neurogenic differentiation of amniotic fluid stem cells. | Q37875778 |
| | Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases | Q37953498 |
| | Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. | Q38452430 |
| | Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation | Q39441790 |
| | Probing stemness and neural commitment in human amniotic fluid cells | Q39729063 |
| | Embryoid body formation of human amniotic fluid stem cells depends on mTOR. | Q39771151 |
| | Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway | Q39818894 |
| | Expression of mTOR pathway proteins in human amniotic fluid stem cells | Q39855092 |
| | Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells | Q40370235 |
| | Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? | Q40578057 |
| | Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. | Q43027547 |
| | In vitro differentiation of human amniotic fluid-derived cells: augmentation towards a neuronal dopaminergic phenotype | Q43101313 |
| | Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels | Q44280495 |
| | Human and murine amniotic fluid c-Kit+Lin- cells display hematopoietic activity | Q46120327 |
| | Potential role of culture mediums for successful isolation and neuronal differentiation of amniotic fluid stem cells | Q46981766 |
| | Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts. | Q47807049 |
| | Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice | Q48111461 |
| | Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. | Q50472629 |
| | Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells. | Q50748415 |
| | Chondrogenic differentiation of amniotic fluid-derived stem cells. | Q50946606 |
| | Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. | Q55041824 |
| | Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells | Q56768636 |
| | Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation | Q73756569 |
| | Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells | Q84387301 |
| P433 | issue | 3 | |
| P304 | page(s) | 96-100 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Organogenesis | Q15762089 |
| P1476 | title | Amniotic fluid stem cells to study mTOR signaling in differentiation | |
| P478 | volume | 8 | |